Annual Cash & Cash Equivalents
$684.72 M
+$189.95 M+38.39%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual cash & cash equivalents is $684.72 million, with the most recent change of +$189.95 million (+38.39%) on December 31, 2021.
- During the last 3 years, GBT annual cash & cash equivalents has risen by +$409.36 million (+148.67%).
Performance
GBT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$261.15 M
-$130.65 M-33.35%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly cash and cash equivalents is $261.15 million, with the most recent change of -$130.65 million (-33.35%) on June 30, 2022.
- Over the past year, GBT quarterly cash and cash equivalents has dropped by -$158.16 million (-37.72%).
Performance
GBT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GBT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.4% | -37.7% |
| 3 y3 years | +148.7% | -22.8% |
| 5 y5 years | +245.2% | +178.6% |
GBT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -61.9% | at low |
| 5 y | 5-year | at high | -55.9% | -61.9% | at low |
| alltime | all time | at high | -99.5% | -61.9% | -84.5% |
Global Blood Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $261.15 M(-33.3%) |
| Mar 2022 | - | $391.80 M(-42.8%) |
| Dec 2021 | $684.72 M(+38.4%) | $684.72 M(+78.8%) |
| Sep 2021 | - | $382.87 M(-8.7%) |
| Jun 2021 | - | $419.31 M(-5.8%) |
| Mar 2021 | - | $445.31 M(-10.0%) |
| Dec 2020 | $494.77 M(+63.7%) | $494.77 M(+18.3%) |
| Sep 2020 | - | $418.40 M(+8.8%) |
| Jun 2020 | - | $384.72 M(+21.9%) |
| Mar 2020 | - | $315.52 M(+4.4%) |
| Dec 2019 | $302.24 M(+9.8%) | $302.24 M(+12.9%) |
| Sep 2019 | - | $267.60 M(-20.9%) |
| Jun 2019 | - | $338.45 M(+115.8%) |
| Mar 2019 | - | $156.84 M(-43.0%) |
| Dec 2018 | $275.36 M | $275.36 M(+41.3%) |
| Sep 2018 | - | $194.89 M(-43.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $342.10 M(-24.9%) |
| Mar 2018 | - | $455.64 M(+129.7%) |
| Dec 2017 | $198.33 M(+115.4%) | $198.33 M(+135.7%) |
| Sep 2017 | - | $84.15 M(-10.2%) |
| Jun 2017 | - | $93.74 M(-30.9%) |
| Mar 2017 | - | $135.74 M(+47.4%) |
| Dec 2016 | $92.07 M(-38.0%) | $92.07 M(-57.7%) |
| Sep 2016 | - | $217.84 M(-6.1%) |
| Jun 2016 | - | $231.91 M(+73.1%) |
| Mar 2016 | - | $133.98 M(-9.8%) |
| Dec 2015 | $148.50 M(+185.2%) | $148.50 M(-6.3%) |
| Sep 2015 | - | $158.50 M(+290.6%) |
| Jun 2015 | - | $40.58 M(-11.4%) |
| Mar 2015 | - | $45.80 M(-12.0%) |
| Dec 2014 | $52.07 M(+1488.4%) | $52.07 M |
| Dec 2013 | $3.28 M | - |
FAQ
- What is Global Blood Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual cash & cash equivalents year-on-year change?
- What is Global Blood Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Global Blood Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of GBT is $684.72 M
What is the all time high annual cash & cash equivalents for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual cash & cash equivalents is $684.72 M
What is Global Blood Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, GBT annual cash & cash equivalents has changed by +$189.95 M (+38.39%)
What is Global Blood Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GBT is $261.15 M
What is the all time high quarterly cash and cash equivalents for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly cash and cash equivalents is $684.72 M
What is Global Blood Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, GBT quarterly cash and cash equivalents has changed by -$158.16 M (-37.72%)